OBJECTIVE: While the prevalence of radiographic thumb carpometacarpal (CMC1) osteoarthritis (OA) is well-described, little is known about clinically symptomatic disease presenting to physicians for care. We sought to determine the prevalence of doctor-diagnosed CMC1 OA. METHODS: Using health care data from Skåne in southern Sweden (population 1.24 million), we identified all adults ages >20 years who consulted a physician at least once and received a diagnosis for CMC1 OA (International Classification of Diseases, Tenth Revision, code M18). Data from the 15-year period 1998–2012 were analyzed. Using cross-referencing with the Swedish population register to exclude subjects who were deceased or had relocated, we obtained point estimates of the proportion of the population consulting for CMC1 OA. RESULTS: The prevalence of doctor-diagnosed CMC1 OA in adults was estimated at 1.4% (2.2% in women and 0.62% in men). The mean±SD age in the prevalent CMC1 cohort (n=11,111) was 67.7±11.4 years; 78.5% of diagnoses were in women. Prevalence peaked in women ages 70–74 years with an estimate of 5.3% and in men ages 80–84 years with an estimate of 1.7%. Age at initial diagnosis also differed, with women presenting between ages 60–69 years and men presenting between ages 70–79 years. CONCLUSION: The clinically important prevalence of CMC1 OA is 3 to 4 times higher in women than men. By the end of2012, more than 1 in 20 elderly women had consulted a physician for CMC1 OA over the last 15 years. The high prevalence of this subset of hand OA is a concern in an aging population.
OBJECTIVE: While the prevalence of radiographic thumb carpometacarpal (CMC1) osteoarthritis (OA) is well-described, little is known about clinically symptomatic disease presenting to physicians for care. We sought to determine the prevalence of doctor-diagnosed CMC1 OA. METHODS: Using health care data from Skåne in southern Sweden (population 1.24 million), we identified all adults ages >20 years who consulted a physician at least once and received a diagnosis for CMC1 OA (International Classification of Diseases, Tenth Revision, code M18). Data from the 15-year period 1998–2012 were analyzed. Using cross-referencing with the Swedish population register to exclude subjects who were deceased or had relocated, we obtained point estimates of the proportion of the population consulting for CMC1 OA. RESULTS: The prevalence of doctor-diagnosed CMC1 OA in adults was estimated at 1.4% (2.2% in women and 0.62% in men). The mean±SD age in the prevalent CMC1 cohort (n=11,111) was 67.7±11.4 years; 78.5% of diagnoses were in women. Prevalence peaked in women ages 70–74 years with an estimate of 5.3% and in men ages 80–84 years with an estimate of 1.7%. Age at initial diagnosis also differed, with women presenting between ages 60–69 years and men presenting between ages 70–79 years. CONCLUSION: The clinically important prevalence of CMC1 OA is 3 to 4 times higher in women than men. By the end of2012, more than 1 in 20 elderly women had consulted a physician for CMC1 OA over the last 15 years. The high prevalence of this subset of hand OA is a concern in an aging population.
Authors: Anusha Ratneswaran; Jason S Rockel; Daniel Antflek; John J Matelski; Konstantin Shestopaloff; Mohit Kapoor; Heather Baltzer Journal: Front Immunol Date: 2022-01-20 Impact factor: 7.561
Authors: Catherine M Gavile; Nikolas H Kazmers; Kendra A Novak; Huong D Meeks; Zhe Yu; Joy L Thomas; Channing Hansen; Tyler Barker; Michael J Jurynec Journal: J Hand Surg Am Date: 2022-09-29 Impact factor: 2.342
Authors: E M Ooms; B ten Brinke; N M C Mathijssen; I F Blom; R L M Deijkers; G A Kraan Journal: BMC Musculoskelet Disord Date: 2015-10-14 Impact factor: 2.362